FDA Adverse Event Death Summary report: N

DEFLUX INJECTABLE GEL

MDR report key: 7346980 · Received March 16, 2018

Report

Report Number
3009443653-2018-00009
Event Type
Death
Date Received
March 16, 2018
Report Date
February 22, 2018
Manufacturer
BAUSCH + LOMB
Product Code
LNM
PMA / PMN Number
P000029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED. A DEVICE LOT NUMBER WAS NOT REPORTED, SO A DEVICE HISTORY RECORD (DHR) REVIEW COULD NOT BE PERFORMED. BASED ON THE AVAILABLE INFORMATION, A ROOT CAUSE FOR THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED.

Additional Manufacturer Narrative · 1

INVESTIGATION OF THIS EVENT IS IN PROGRESS. A FOLLOW-UP REPORT WILL BE SUBMITTED UPON COMPLETION OF THE INVESTIGATION.

Description of Event or Problem · 1

A PUBLISHED ARTICLE TITLED "DETERIORATION OF AUTOIMMUNE CONDITION ASSOCIATED WITH REPEATED INJECTION OF DEXTRANOMER/HYALURONIC ACID COPOLYMER: A CASE REPORT" REPORTS A DIAGNOSED CASE OF URETERAL STENOSIS APPROXIMATELY 2 YEARS AFTER INJECTION. A (B)(6)-YEAR OLD FEMALE PATIENT UNDERWENT ENDOSCOPIC DEFLUX INJECTION (EDI) FOR THE TREATMENT OF BILATERAL VUR OF GRADE 2. ANOTHER EDI WAS PERFORMED BECAUSE CYSTOURETHROGRAM AT 3 MONTHS POST-OPERATIVE SHOWED A PERSISTENT LEFT VUR OF GRADE 2. ONE AND A HALF YEARS AFTER, SHE CLAIMED LEFT FLANK PAIN. ULTRASOUND EXAMINATION SHOWED LEFT HYDRONEPHROSIS HYDROURETER, AND DELAYED EXCRETION FROM THE LEFT KIDNEY WAS OBSERVED BY MAG3. DELAYED ONSET OF URETERAL STENOSIS WAS DIAGNOSED, AND A URETERAL STENT WAS PLACED. SHE ALSO PRESENTED WITH ERYTHEMA ON BOTH CHEEKS AND RAYNAUD¿S PHENOMENON; AUTOIMMUNE DISEASE WAS SUSPECTED. SINCE A RELATIONSHIP WITH THE AUTOIMMUNE DISEASE WAS ALSO SUSPECTED, A RISK OF DEVELOPING A HETEROCHRONIC RIGHT URETERAL STENOSIS WAS CONCERNED, AND URETEROCYSTONEOSTOMY (UCN) ON BOTH SIDES WAS PERFORMED, WITH SATISFACTORY POSTOPERATIVE COURSE. SIGNIFICANT INFILTRATION OF EOSINOPHIL TO THE AREA OF URETERAL STENOSIS WAS OBSERVED HISTOPATHOLOGICALLY, AND THE PATIENT DIED OF PULMONARY HEMORRHAGE DUE TO THROMBOTIC THROMBOCYTOPENIC PURPURA 4 MONTHS AFTER UCN. REACTIVE STENOSIS ACCOMPANIED BY ALLERGY WAS SUGGESTED IN THIS CASE. IT WAS CONSIDERED THAT THE TREATMENT OF EDI SHOULD BE DISCUSSED MORE CAREFULLY TO A PATIENT WHO PREDISPOSES TO ALLERGIES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
188735 DEFLUX INJECTABLE GEL AGENT,BULKING,INJECTABLE FOR GASTRO-UROLOGY USE LNM BAUSCH + LOMB DEFLUX INJECTABLE GEL

Patients

Seq Age Sex Outcome Treatment
1 8 YR Death| R